UNSPSC 51312900: Antihistamine or H1 blocker phenanthrolines

Antihistamine or H1 blocker drugs made from 1,10-phenanthroline.

UNSPSC 51312900 Antihistamine or H1 blocker phenanthrolines is a Class code, but the recent state and local opportunities posted under it do not align with the code's nominal scope. Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems through IFB 60459723LAS (response due July 26, 2023); the Texas Health and Human Services Commission issued an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across state and local facilities. None of these opportunities involve antihistamines or H1 blockers as their primary procurement focus. The code shows little relevant recent activity; the mismatch suggests either miscoding in the source data or that state and local buyers are not actively soliciting under this specific UNSPSC designation.

When opportunities do post under this code, they reflect broader pharmaceutical and health-product procurement by county health departments, state health agencies, and cooperative purchasing consortia serving multiple jurisdictions. Geographic activity has centered on Florida and Minnesota in the recent period, with multistate coordination visible through MMCAP's involvement of Oregon alongside Minnesota participants. Issuing bodies include county health departments, state HHS commissions, and intergovernmental cooperative purchasing alliances. Prospective vendors should monitor whether future activity corrects the coding mismatch or if the code remains underutilized for antihistamine-specific procurements in the state and local market.